Fukuoka Cancer General Clinic: Advanced Apheresis and Activated Immunotherapy
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Located in the heart of Fukuoka City, Fukuoka Cancer General Clinic provides immune cell therapy in the Kyushu region. The Director, Dr. Takashi Morisaki, formerly of Kyushu University Hospital, brings a deep background in oncology research and is dedicated to providing patients with scientific, rigorous, and compassionate personalized medical care.
Apheresis Technology
The clinic's distinctive feature is its use of "Apheresis" technology, equivalent to that used in large university hospitals:
- Precision Extraction: Only the required immune cells (such as T cells and NK cells) are extracted from the blood, while the remaining components are immediately returned to the patient's body.
- Reduced Physical Burden: A single collection provides enough cells for an entire course of nurturing care, avoiding the physical exhaustion of frequent blood draws for patients in advanced stages.
【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free (initial direction only; further services are quoted separately); an advisor will help you clarify the next steps.